Results

eNauka >  Results >  Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
Title: Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
Authors Szarek, Michael; ...; Dilić, Mirza; ...; Ristić, Arsen D.  ; ...; Miličić, Davor; ...; Simić, Dragan V.  ; Ivanović, Nikola;
Issue Date: 2019
Publication: Journal of the American College of Cardiology
ISSN: 0735-1097 e1558-3597 Journal of the American College of Cardiology Search Idenfier
Publisher: Elsevier Biomedical, New York
Type: Article
Collation: vol. 73 br. 4 str. 387-396
DOI: 10.1016/j.jacc.2018.10.039
WoS-ID: 000456818200001
Scopus-ID: 2-s2.0-85060287356
URI: https://enauka.gov.rs/handle/123456789/821567
URL: https://www.sciencedirect.com/science/article/pii/S0735109718389617?via%3Dihub
Project: Sanofi-Aventis
Regeneron Pharmaceuticals, Inc.
Fondation Assistance Publique-Hopitaux de Paris
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

147
SCOPUSTM
107
OpenCitations
145
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.